Biotech, Food & Drug

HB Ad Slot
HB Mobile Ad Slot

In today’s hyper-aware environment, concerns about food and drug safety are paramount for both companies and consumers.  The Food and Drug Administration (FDA) and the US Department of Agriculture (USDA) regulates the areas of biotech, food, and drug law. Additionally, laws including the 21st Century Cures Act, and cGMP (Current Good Manufacturing Processes), regulate industry standards/norms in food, cosmetics, and other industry-sectors. Visitors to the National Law Review will find the latest analysis of news, legislation, and upcoming cases/litigation as it relates to this area of law.

With researchers searching for new energy solutions and other developments in biotech, visitors to the NLR will have the opportunity to read content surrounding biosimilars, natural fuel production, medical devices, biotechnology, nanotechnology and materials, and the pharmaceuticals industry. Additionally, content relating to food and drug laws, limits on chemical use in cosmetic products, and other general health/safety topics are covered by the National Law Review and are updated regularly. Additionally, food safety and imports to the United States are also discussed as they become relevant. 

In addition to general health, science, and food/drug, the industry is also closely related to many of the issues related to intellectual property law. New applications for patents, intellectual property, licensing laws, and other areas which are governed by the PTAB court, often crossover into the industry.

New developments in legislation, including the legalization of recreational marijuana has created a new area ripe for legal analysis.  Regulations on how recreational marijuana can be advertised and marketed, distributed and the kind of insurance coverage necessary for dispensaries.  Additionally, employer drug-testing and marijuana statutes have been a hot area of litigation covered by the National Law Review.  

General practices in marketing standards, compliance of federal and state laws/legislation, licensing collaborations, and news related to bringing new products to the market, in the US and abroad, are among the areas visitors to NLR will read about daily. Drug pricing, changes in production standards, regulatory compliance, food safety and handling, drug laws (legalization of marijuana, both recreational and medicinal in the workplace), and labeling and nutritional requirements, are among the many topics covered by the National Law Review daily.

Visitors will always find the latest, up-to-date, most comprehensive coverage on the site. And, news and stories which affect the US, companies which are regulated in the industry, and multinational/international companies, are detailed regularly for NLR readers.

National Law Review Cannabis TwitterFor hourly updates on the latest news about biotech, food & drug, and cannabis laws, regulations, and legislation, be sure to follow our Cannabis X (formerly Twitter) feed, and sign up for complimentary e-news bulletins.

Recent Biotechnology, Food & Drug Administration FDA News

Title
Publication Date Organization Sort ascending
Jan
8
2024
Gold Dome Report – Legislative Day 1 (2024) Nelson Mullins
Mar
6
2023
Old North State Report – March 6, 2023 Nelson Mullins
Nov
9
2023
Proposed Changes to California Proposition 65 Warnings, Safe Harbor Methods & Content Nelson Mullins
May
6
2024
Old North State Report – May 6, 2024 Nelson Mullins
Sep
11
2023
Old North State Report – Sept. 11, 2023 Nelson Mullins
Mar
21
2024
FDA Publishes Paper Detailing Actions It Intends to Take Regarding the Uses of AI Across the Medical Product Life Cycle Nelson Mullins
Mar
21
2024
A Psychedelic Use Case for AI Nelson Mullins
Feb
13
2023
Old North State Report – Feb. 13, 2023 Nelson Mullins
Mar
23
2023
FDA Revises Recommendations Regarding Electronic Systems, Records, and Signatures in Clinical Investigations Nelson Mullins
May
30
2023
FDA Studies Foreshadow Potential Changes to Direct-to-Consumer Prescription Drug Advertising Nelson Mullins
May
7
2021
Court Issues a Rare, Severe Discovery Sanction: The Path that Led to Default Judgment Nelson Mullins
May
25
2023
FDA Establishes Public Docket Soliciting Comments on Nitrosamine Drug Substance-Related Impurities Nelson Mullins
Jun
16
2023
NEWMOA Releases First-of-its-kind PFAS Regional Draft Model Legislation for Public Comment Nelson Mullins
Mar
19
2022
Gold Dome Report – Legislative Day 31 Nelson Mullins
Jun
20
2022
Transgender Youth and Access to Healthcare Nelson Mullins
Jan
31
2023
Old North State Report – Jan. 30, 2023 Nelson Mullins
Jan
18
2023
First Major Overhaul of Cosmetics Regulation Since FDR Administration Nelson Mullins
Jan
25
2023
FDA Finalizes Cannabis Guidance Focusing on Clinical Research and Quality Considerations Nelson Mullins
Jan
29
2024
Gold Dome Report – Legislative Day 10 (2024) Nelson Mullins
Jul
12
2021
Biden Executive Order Addresses Healthcare Industry Competition, Targets Pharmaceuticals, Pricing, and Hospital Mergers Nelson Mullins
Apr
6
2023
FDA Announces First-Ever AI/ML Medical Device Draft Guidance Nelson Mullins
Jun
30
2023
Old North State Report – June 30, 2023 Nelson Mullins
Apr
17
2023
FDA Publishes Implementation Policy Regarding Cybersecurity Requirements for Medical Device Premarket Submissions Nelson Mullins
Jun
12
2023
New FDA Draft Guidance Updates Recommendations for Good Clinical Practices Nelson Mullins
Jul
10
2023
Payment Cuts and Program Changes: CMS Issues Calendar Year 2024 Home Health Prospective Payment System Proposed Rule Nelson Mullins
Aug
31
2023
Two New Drug Supply Chain Security Act Guidance to Help Pharmaceutical Supply Chain Partners Comply with the DSCSA’s Move to Electronic Tracking Nelson Mullins
Oct
24
2023
FDA Updates Guidance Regarding Scientific Communications to HCPs about Unapproved Uses of Approved/Cleared Medical Devices and Drugs Nelson Mullins
Jan
22
2024
Gold Dome Report – Legislative Day 6 (2024) Nelson Mullins
 

NLR Logo

We collaborate with the world's leading lawyers to deliver news tailored for you. Sign Up to receive our free e-Newsbulletins

 

Sign Up for e-NewsBulletins